RONALD REAGAN UCLA — History
CCN 050262 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$2.6B
Latest Revenue (FY2022)
+9.1%
Revenue CAGR (3yr)
-6.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $2.2B | $2.3B | $2.6B | +14.0% | +9.1% |
| Operating Expenses | $2.2B | $2.6B | $2.8B | +7.3% | +12.0% |
| Operating Margin | -1.3% | -13.5% | -6.8% | +49.6% | +0.0% |
| Net Income | $-29M | $-310M | $-178M | +42.5% | +0.0% |
| Licensed Beds | 446 | 446 | 446 | +0.0% | +0.0% |
| Total Patient Days | 158,975 | 168,022 | 178,576 | +6.3% | +6.0% |
| Medicare Day % | 25% | 25% | 23% | -7.0% | -4.5% |
| Medicaid Day % | 16% | 15% | 14% | -6.4% | -7.3% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +19.0% ($2.2B → $2.6B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.1%
This Hospital
+7.6%
State Avg
Latest Margin
-6.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $2.8B | -9.5% |
| FY2024 (proj) | $3.0B | -12.3% |
| FY2025 (proj) | $3.2B | -15.0% |